|Articles|May 6, 2019

Clinerion Partners with CCRI

Clinerion has announced its partnership with the Czech Clinical Research Institute (CCRI) to bring its services to patients in the Czech Republic and Slovakia. The CCRI will support patients and physicians in those areas in accessing new treatments by expanding Clinerion’s hospital and patient coverage into those countries.

For more, click here.

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Subscribe Now!

Related Content

© Africa Studio - © Africa Studio - stock.adobe.com

FDA Approves UCB’s Kygevi for TK2 Deficiency Based on Multi-Study Clinical Program Demonstrating Significant Survival and Motor Gains

ByAndy Studna, Senior Editor

November 5th 2025

Clinerion Partners with CCRI

Newsletter

Related Content

Novo Nordisk’s Phase III OASIS 4 Analyses Highlight Cardiometabolic Benefits of Oral Semaglutide 25 mg

Eli Lilly’s Phase II Trial of Eloralintide Shows Up to 20% Weight Reduction in Adults With Obesity

ACT Brief: Data Strategy, AI Integration, and Rare Disease Milestones Drive Clinical Innovation

Designing Feasible Protocols with Real-World Data

FDA Approves UCB’s Kygevi for TK2 Deficiency Based on Multi-Study Clinical Program Demonstrating Significant Survival and Motor Gains

Trending on Applied Clinical Trials Online

Eli Lilly’s Phase II Trial of Eloralintide Shows Up to 20% Weight Reduction in Adults With Obesity

Novo Nordisk’s Phase III OASIS 4 Analyses Highlight Cardiometabolic Benefits of Oral Semaglutide 25 mg

Designing Feasible Protocols with Real-World Data

Inside the Recruitment Bottlenecks Driving Trial Delays

ACT Brief: Data Strategy, AI Integration, and Rare Disease Milestones Drive Clinical Innovation